Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 148
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

How does sleep deprivation impact problematic eating?

Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

Backer Badge Funded